HomeSLDB • NASDAQ
Solid Biosciences Inc
add
$3.84
9.71%
After Hours:(1.30%)-0.050
$3.79
Closed: Jun 4, 6:53:40 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.14M | 14.38% |
Net income | -39.28M | -61.63% |
Net profit margin | — | — |
Earnings per share | -0.59 | 7.81% |
EBITDA | -39.65M | -49.41% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 306.92M | 48.94% |
Total assets | 343.90M | 38.29% |
Total liabilities | 49.44M | 30.23% |
Total equity | 294.46M | — |
Shares outstanding | 77.52M | — |
Price to book | 0.92 | — |
Return on assets | -37.60% | — |
Return on capital | -41.76% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -39.28M | -61.63% |
Cash from operations | -31.85M | -26.43% |
Cash from investing | -27.46M | 28.65% |
Cash from financing | 189.73M | 76.92% |
Net change in cash | 130.42M | 199.40% |
Free cash flow | -20.99M | -22.47% |
Previous close
$3.50
Day range
$3.41 - $3.94
Year range
$2.41 - $10.37
Market cap
297.66M USD
Avg Volume
1.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2013
Website
Employees
100
